by Benjamin Adams
Opioids, while essential for managing pain in some cases, have become a devastating force across the United States, leaving a trail of addiction and loss in their wake. The physical dependence and life-threatening risks tied to these drugs wreak havoc on families and...
by Cole Fullmer
Opioids have devastated families across Utah, mine included. But a quiet shift is happening—one story, one patient at a time. Cannabis, once villainized, is now offering something opioids never could: control, clarity, and a way forward. This isn’t about politics or...
by Cole Fullmer
Utah’s cannabis scene is evolving, and at the heart of it is Buzz, a craft flower brand that brings top-shelf genetics and a deep-rooted passion for the plant to medical cannabis patients statewide. More than just another flower label, Buzz is the personal project of...
by Cole Fullmer
Moxie has been a heavyweight in cannabis since day one, and Utah’s medical market is no exception. From the moment their products hit pharmacy shelves, patients took notice—whether it’s live resin, rosin, distillate carts, or a diverse lineup of concentrates and...
by Cole Fullmer
Utah’s medical cannabis landscape might be on the verge of a major shift—but there are still big questions to answer. House Bill 203 S2 just received a favorable recommendation from the Natural Resources, Agriculture, and Environment House Committee, and if it moves...
by Cole Fullmer
Utah’s cannabis patients know quality when they see it, and if you’ve picked up a Moxie product, you’ve likely experienced some of the best concentrates and edibles the market has to offer. But what many patients might not realize is that the same exceptional team...